IL17A and cancer: A joint analysis of the network prediction approach and RNA-Seq revealed that the inhibitory mechanism of RD-6 for GU may involve multiple pathways, such as the AGE-RAGE signaling pathway, pathways in cancer, and the IL-17 signaling pathway.